BVT Aktienanleihe AMD 28.03.2025/ DE000VD2UAB1 /
2024-05-02 1:54:09 PM | Chg.-3.890 | Bid1:56:19 PM | Ask1:56:19 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
90.500EUR | -4.12% | 90.420 Bid Size: 50,000 |
90.520 Ask Size: 50,000 |
ADVANCED MIC.DEV. D... | 180.00 - | 2025-03-28 | Call |
GlobeNewswire
05-01
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 A...
GlobeNewswire
05-01
Gene Therapies in Degenerative Retinal Disease Hold Potential to Capture Significant Portion of Mark...
GlobeNewswire
05-01
Alkeus Pharmaceuticals Announces Presentation of Positive Gildeuretinol Data in Early-Stage Stargard...
GlobeNewswire
05-01
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geog...
GlobeNewswire
05-01
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024
GlobeNewswire
05-01
Apellis Announces 11 Oral Presentations at the Association for Research in Vision and Ophthalmology ...
GlobeNewswire
04-30
Lighthouse Guild Receives Grant from American Macular Degeneration Foundation (AMDF)
GlobeNewswire
04-25
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientif...
GlobeNewswire
04-18
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy